What is the recommended dose of Teicoplanin (injection Teicoplanin)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 21, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Teicoplanin Dosing Recommendations

For standard infections, administer teicoplanin with a loading dose of 6 mg/kg IV every 12 hours for three doses, followed by 6 mg/kg once daily maintenance; for severe infections (endocarditis, septic arthritis, complicated bacteremia), use a loading dose of 12 mg/kg IV every 12 hours for three doses, followed by 12 mg/kg once daily maintenance. 1, 2

Standard Dosing Algorithm

Loading Phase

  • Standard infections: 6 mg/kg IV every 12 hours for three doses (total of three doses over 48 hours) 3, 1
  • Severe infections (S. aureus endocarditis, septic arthritis, complicated bacteremia): 12 mg/kg IV every 12 hours for three doses 1, 2, 4
  • The higher loading dose is critical for achieving rapid therapeutic concentrations, with 90-100% of patients reaching target levels by days 2-3 compared to only 16-18% with standard dosing 5

Maintenance Phase (Normal Renal Function)

  • Standard infections: 6 mg/kg IV once daily 1, 6
  • Severe infections: 12 mg/kg IV once daily to achieve target trough ≥20 mg/L 1, 2, 7
  • For endocarditis specifically, 12 mg/kg daily or combination therapy with aminoglycosides is necessary, as monotherapy with 6 mg/kg has shown inferior cure rates 7

Infection-Specific Dosing

Complicated Skin and Soft Tissue Infections

  • 6-12 mg/kg IV every 12 hours for three doses, then once daily 3, 1
  • Duration: 7-14 days 3, 1

Bacteremia

  • Uncomplicated: 6-12 mg/kg IV every 12 hours for three doses, then once daily for 2 weeks 3, 1
  • Complicated: 6-12 mg/kg IV every 12 hours for three to six doses, then 6-12 mg/kg once daily for 4-6 weeks 3, 1

Endocarditis

  • Native valve: 12 mg/kg IV every 12 hours for three doses, then 12 mg/kg once daily for 4-6 weeks 1, 4, 7
  • Prosthetic valve: Same dosing for 6 weeks in combination with rifampin and gentamicin 1
  • Target trough concentration ≥20 mg/L 2, 4

Pneumonia

  • 6-12 mg/kg IV every 12 hours for three doses, then 6-12 mg/kg once daily 3
  • Duration: 7-21 days depending on clinical response 1

Osteomyelitis and Septic Arthritis

  • 12 mg/kg IV every 12 hours for three doses, then 12 mg/kg once daily 1, 7
  • Duration: >6 weeks for osteomyelitis, 3-4 weeks for septic arthritis 1

Renal Dose Adjustments

Maintenance Dosing by GFR

  • GFR >90 mL/min: Every 24 hours 1
  • GFR 50-90 mL/min: Every 24 hours 1
  • GFR 10-50 mL/min: Every 48 hours 1, 2
  • GFR <10 mL/min: Every 72 hours 1

Hemodialysis

  • Loading: 12 mg/kg, then 6 mg/kg on days 2 and 3 1, 2
  • Maintenance: 6 mg/kg once weekly 1, 2

Critical Pitfalls to Avoid

Inadequate Loading Doses

  • The standard 400 mg daily dose (approximately 6 mg/kg) frequently results in subtherapeutic levels, with only 37% achieving target concentrations 8
  • For severe infections, failure to use 12 mg/kg loading doses delays therapeutic levels by several days 5

Premature Transition to Oral Therapy

  • Maintain parenteral therapy throughout the treatment course for complicated bacteremia and endocarditis 1
  • Oral transition should not be done in complicated bacteremia to prevent relapse 1

Inadequate Maintenance Dosing for Severe Infections

  • Using 6 mg/kg daily for endocarditis as monotherapy has shown poor cure rates compared to vancomycin 7
  • Either increase to 12 mg/kg daily or add aminoglycoside combination therapy 7

Stopping Therapy Based on Symptom Resolution

  • Complete the full duration based on infection type (4-6 weeks for complicated bacteremia, 4-6 weeks for endocarditis) to prevent relapse 1

Therapeutic Drug Monitoring

  • Not routinely required for standard infections 1
  • Indicated for: S. aureus endocarditis, septic arthritis, major burns, IV drug users, rapidly changing renal function 1
  • Target trough for severe infections: ≥20 mg/L 1, 2, 4
  • Higher doses (600 mg daily in adults with normal renal function) achieve therapeutic levels in 68% of patients without increased toxicity 8

References

Guideline

Teicoplanin Dosing Regimen

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Teicoplanin Dosing Regimen for Severe Infections

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Teicoplanin in the treatment of serious infection.

Journal of chemotherapy (Florence, Italy), 2000

Research

A critical review of the dosage of teicoplanin in Europe and the USA.

International journal of antimicrobial agents, 1994

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.